THE TEAM
Discover the passion and expertise of our team at One Six 8 Ventures, committed to advancing Canadian health and life sciences investments. Our impactful initiatives and strategic vision set us apart as leaders, shaping the future landscape of these industries. Join us as we drive innovation and growth in Canadian health and life sciences.
Judyanna Yu, CPA, CAManaging Partner
CFO, Providence Therapeutics CFO & COO, Restem Biotech CFO, Biochem Group VP Corporate Finance, Cerecin Health business entrepreneur Previous: Manning Elliott LLP, KPMG, Auditor General of Alberta Board, BioAlberta Board, Pharmsky Research |
Charles Stacey, MD, MBAPartner
President & CEO, Cerecin Inventages Venture Capital ($1.5B AUM) Orthopaedics and trauma surgeon in London Medtech entrepreneur Board of Governors, Accreditation Council for Medical Affairs |
Ankang Li, PhD, JD, CFAAdvisor
CFO, CSO and Executive Director, Brii Biosciences CEO, TSB Therapeutics CFO, Terns Pharmaceutical Executive Director, Healthcare Investment Banking, Goldman Sachs, BD Director, Merck, Associate at Davis Polk, Ropes & Gray |
Xi Qiao, MScPrincipal
Head of BD Commercial Evaluation, Fosun Pharma, Consultant at Boston Consulting Group, Pricing and Market Access Manager, AstraZeneca, Health & TMT Senior Consultant, Ernst & Young |
About
At One Six 8 Ventures, we are dedicated partners in the pursuit of innovation and growth within the Health and Life Science industry. Our passion for impactful investing drives us to see endless possibilities for transformative change.
Our mission is clear: to empower early-stage companies to revolutionize healthcare and life sciences through impactful investing. By nurturing innovation at its inception, we aim to shape a brighter future for all stakeholders.
Our dynamic team comprises seasoned leaders in C-suite roles for life sciences companies, boasting diverse backgrounds ranging from medical and business expertise to financial acumen. With a robust track record in steering companies from growth to successful exit strategies, our team brings a wealth of expertise to support and mentor the ventures we invest in, ensuring that impactful investing principles are seamlessly integrated into the advancement of healthcare and life sciences.
Our mission is clear: to empower early-stage companies to revolutionize healthcare and life sciences through impactful investing. By nurturing innovation at its inception, we aim to shape a brighter future for all stakeholders.
Our dynamic team comprises seasoned leaders in C-suite roles for life sciences companies, boasting diverse backgrounds ranging from medical and business expertise to financial acumen. With a robust track record in steering companies from growth to successful exit strategies, our team brings a wealth of expertise to support and mentor the ventures we invest in, ensuring that impactful investing principles are seamlessly integrated into the advancement of healthcare and life sciences.
